Basel, 2005/02/23

Genedata announces collaboration with the Basel-based Friedrich Miescher Institute for Biomedical Research (FMI), a branch of the Novartis Research Foundation. In the frame of the collaboration, the FMI has licensed Genedata Expressionist® computational system for gene expression analysis to support the Institute's research activities in epigenetics, growth control, and neurobiology.

"The collaboration between the FMI and Genedata neatly complements our strategic path to work with world-class research organizations and establish the next generation systems biology platform," added Dr. Othmar Pfannes, CEO of Genedata. "Our solutions for integrating disparate technologies, including high throughput transcriptomics, proteomics and metabolomics, enable research organizations to better understand and simulate cellular processes."

"Expressionist offers a holistic approach to data analysis and interpretation that allows many strands of information to be seamlessly integrated into a human-readable conclusion based on sound statistical principles," stated Dr. Edward J. Oakeley, Head Functional Genomics at FMI. "Our collaboration with Genedata will enable us to extract quickly the maximum value from our microarray experiments."

"Expressionist integrates automated microarray quality assessment and advanced tools for statistical analysis and biological interpretation with scalable database capabilities for raw (uncondensed) and condensed data and result reports," explained Dr. Jens Hoefkens, Expressionist's Project Manager at Genedata. "We've installed our highly automated workflow system to support the FMI's high quality needs and enable their scientists to pursue sophisticated data analysis and interpretation."